Loss of DGKζ results in reduced PD-1 expression and promotes the expansion of cytotoxic CD8+ T cells, even in immunosuppressive environments, suggesting that targeting DGKζ could enhance anti-tumor immunity [162]. This evidence concerns the gene DGKZ and neoplasm.